Navigation Links
HTG-Ventrex, Signalife's Contract Manufacturer, Acquired by Parker Hannifin Corporation
Date:4/28/2008

GREENVILLE, S.C., April 28 /PRNewswire-FirstCall/ -- Signalife, Inc. (Amex: SGN) announced today that its contract manufacturer, Ventrex Inc., Ventura, CA, acquired by the Hi-Tech Group in September 2007, has been acquired by Parker Hannifin Corporation (NYSE: PH), Cleveland, OH as part of the Parker Hannifin strategic entry into the medical device manufacturing industry. The Hi-Tech Group, a 2007 Medical Design Excellence Award winner, combines the strength of Ventrex with other engineering, molding, assembly and plastics companies expanding its technical service offering to Signalife and the medical device industry. Signalife is pleased to have chosen Ventrex, Inc., a highly responsive and capable full service medical device contract manufacturer with ISO 13485 certification and FDA registration, as its contract manufacturer. With a broad array of process capabilities, foremost attention to quality, total responsiveness, and highly efficient operation, Ventrex offers superior value in medical device contract manufacturing services.

Dr. Budimir S. Drakulic, Signalife's Chief Technology Officer commented: "This acquisition is very important for Signalife's manufacturing capabilities. We have a great business relationship with HTG-Ventrex and are glad that they are now part of Medical Systems Division of Parker's Seal Group. Ventrex, Hi-Tech, and now Parker Hannifin remain totally committed to Signalife and its product's success."

About Signalife

Signalife, Inc. is a life sciences company focused on the monitoring, detection and prevention of disease through continuous biomedical signal monitoring. Signalife uses its patented signal technology to design and develop medical devices, therapies and/or technologies that simplify and reduce the costs of cardiovascular disease.

Signalife, Inc. is traded on the American Stock Exchange under the symbol SGN. More information is located at http://www.signalife.com. Clear Data. Trusted Results.

Caution Regarding Forward-Looking Statements

Statements in this release that are not strictly historical are "forward- looking" statements. Forward-looking statements involve known and unknown risks, which may cause Signalife's actual results in the future to differ materially from expected results. Factors which could cause or contribute to such differences include, but are not limited to, failure to complete the development and introduction of heart monitoring and other biomedical devices incorporating Signalife's technology, failure to obtain federal or state or governmental or international regulatory approvals governing heart monitoring and other biomedical devices incorporating Signalife's technology, failure to obtain import and export capabilities in the various countries containing buyers and resellers and hospitals and clinics and doctors for the Signalife devices, inability to obtain physician, patient or insurance acceptance of for heart monitoring and other biomedical incorporating Signalife's technology, and the unavailability of financing to complete management's plans and objectives, including the development of heart monitoring and other biomedical incorporating Signalife's technology. These risks are qualified in their entirety by cautionary language and risk factors set forth and to be further described in Signalife's filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Signalife, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Vystar Corporation and Revertex Malaysia Sign Vytex(TM) NRL Production Contract
2. Contract signed for ESAs Sentinel-3 Earth observation satellite
3. Pennsylvania Contractor Pleads Guilty to Participating in Fraud Conspiracy at New York Presbyterian Hospital
4. SAIC Awarded $16 Million Contract by General Services Administration
5. Precision Therapeutics Adds 8 Million Covered Lives Under Contract
6. SAIC Awarded DIA Intelligence Analysis Contract
7. BurgessGroup Announces Contract Renewal and Software Upgrade by CalOptima
8. eq-life(R) and Fairview Pharmacy Services Announce Multi-Year Consulting Contract with Alegent Health
9. Blue Cross Blue Shield of Arizona Renews EDS Information Technology Services Contract
10. UC RNs Overwhelmingly Approve New Contract
11. RxElite Awarded Anesthetic Gases Multi-Source Contract by Premier Inc., a Purchasing Network for More than 1,500 U.S. Hospitals and 49,000 Other Healthcare Sites
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the ... new design of the shoulder pad. The shoulder pad provides optimal support and ... pain while using cold therapy. By utilizing ice and water that is circulated from ...
(Date:10/12/2017)... ... , ... Asante, a nationally recognized health system in southern ... home health joint venture through an agreement, effective October 1, 2017, to create ... health company with Asante, delivering clinically integrated care, for the past eight years. ...
(Date:10/12/2017)... ... 12, 2017 , ... Dr. Parsa Mohebi, the Los Angeles ... to the newly revamped Cosmetic Town journal section, featuring articles written ... known as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s ... the 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand Rapids-based workplace ... Brightest in Wellness® by Best and Brightest. OnSite Wellness will be honored at ... from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... OBP Medical , a leading ... today announced regulatory approval from Brazil,s ... Nacional de Vigilância Sanitária (ANVISA)) to market ... with integrated LED light source and smoke evacuation ... of a tissue pocket or cavity during surgical ...
(Date:10/2/2017)... 2, 2017 The Rebound mobile app is poised ... reverse the tide of prescription drug addiction. The app empowers ... intake and stepping down their dosage in a safe, controlled ... December 2017; the first 100,000 people to sign up will ... http://www.rebound-solution.com/ ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
Breaking Medicine Technology: